Security record · archived quarter
COGT
Cogent Biosciences, Inc. · Healthcare · Biotechnology
10Tracked holders
—Δ holders
18.90MShares held
$159.29MReported value
+0New positions
−0Exits
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
Ownership over time
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 104 | +4 | 108.47M | $4.20B | +7 | −3 |
| Q1 2026 | 103 | +9 | 108.14M | $4.02B | +15 | −6 |
| Q4 2025 | 92 | +1 | 96.22M | $3.42B | +1 | — |
| Q3 2025 | 20 | +4 | 59.75M | $857.99M | +4 | — |
| Q2 2025 | 13 | -2 | 45.58M | $327.23M | — | −2 |
| Q1 2025 | 12 | -1 | 13.98M | $83.77M | — | −1 |
| Q4 2024 | 13 | 0 | 17.19M | $134.06M | +1 | −1 |
| Q3 2024 | 12 | +2 | 19.61M | $211.75M | +2 | — |
| Q2 2024 | 10 | — | 18.90M | $159.29M | — | — |
Who holds it · Q2 2024
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Point72 Asset Management ✦ | 10.47M | — | $88.27M | 0.3% | n/c | 1 | SEC ↗ |
| 2 | Adage Capital Partners ✦ | 4.25M | — | $35.82M | 0.1% | n/c | 1 | SEC ↗ |
| 3 | Geode Capital Management ✦ (passive) | 1.98M | — | $16.70M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passive) | 1.98M | — | $16.70M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | Millennium Management ✦ | 1.23M | — | $10.38M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 316.85K | — | $2.67M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 316.85K | — | $2.67M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | D. E. Shaw & Co. ✦ | 298.71K | — | $2.52M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | D. E. Shaw & Co. ✦ | 298.71K | — | $2.52M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | Two Sigma Investments ✦ | 149.40K | — | $1.26M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | Fisher Asset Management ✦ | 149.04K | — | $1.26M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 40.62K | — | $343,000 | 0.0% | n/c | 1 | SEC ↗ |
| 13 | Citadel Advisors ✦ | 9.04K | — | $76,241 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 304 holders, 186.07M shares, $6.90B reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
Frequently co-owned
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.
Provenance: Ownership from parsed 13F common-stock positions (tracked universe, comparable sets for changes); insider rows from Forms 3/4/5; stakes from Schedules 13D/13G; every filing links to its original on SEC EDGAR.
Reporting period: Q2 2024 ·
Methodology ·
Get this via the API